The M3 Research Center
Malignome, Metabolome and Microbiome

Zurück zum Hauptmenü
Zum Menü der Einrichtung

574

Address: Otfried-Müller-Straße 37
72076 Tübingen

Office

Phone number: +49 7071 29-82518
Michael Lehmann

E-mail address: m3-office@med.uni-tuebingen.de

Third party funding

Please find in the following a list of the current third party funding The M3 Research Center receives.

Immune signatures of chronic inflammatory human diseases driving cancer - AG Heikenwälder

  • EOS CD-INFLADIS

    Source: Research Foundation Flanders

  • SFB 412

    Source: German Research Foundation (DFG)

  • SFB 156

    Source: German Research Foundation (DFG)

  • SFB 1479

    Source: German Research Foundation (DFG)

  • RITA EJP RD (European Joint Programme on Rare Diseases)

    Source: European Union’s Horizon 2020

  • THRIVE

    Source: European Union’s Horizonneuer Eintrag Immune signatures of chronic inflammatory human diseases driving cancer

Mechanisms that contribute to metabolic diseases - AG Jumpertz-von Schwartzenberg

  • EXC-2124/1-03.007

    Type: ProjektförderungSource: Cluster of Excellence “Controlling Microbes to Fight Infections”

  • Innovation Fund „Microbiome“ 2023

    Type: ProjektförderungSource: German Center for Diabetes Research (DZD)

  • Projektförderung Deutsche Diabetes Gesellschaft

    Type: ProjektförderungSource: Deutsche Diabetes Gesellschaft

  • VH-NG-1619

    Source: Helmholtz Young Investigator Group Mechanisms that contribute to metabolic diseases - AG Jumpertz-von Schwartzenberg

Synthetic biology and antibiotic research - AG Link

  • A defined mixed culture that mimics the nasal microbiome and resembles the chemical ecology of host microbe interactions. - CMFI Collaborative Grant

    Source: Cluster of Excellence - Controlling Microbes to Fight Infections (CMFI)

  • Metabolic engineering of autotrophic E. coli strains for biotechnological production of amino acids from CO2 – DFG Middle East Collaboration

    Source: German Research Foundation (DFG)

  • MINT Innovation Grant - Sustainable production of bio-based amino acids from ethanol through bacterial bioprocesses

    Source: Vector Foundation

  • Two-stage cyanophycin bioprocesses through thermal control of E. coli metabolism

    Source: DFG - Einzelförderung Synthetic biology and antibiotic research - AG Link

Drug-Microbiome-Host-Interactions - AG Maier

  • bioIMPACT: “Personalized effects of antibiotics on the human gut microbiome via high-throughput cultivation” (MA 8164/3-1)Type: Research grant

    Type: Research grantSource: German Research Foundation (DFG)

  • German Centers for Health Research Innovation Fonds: DZG 01.203_00

    Source: German Centers for Health Research

  • gutMAP: Gut microbiome-mediated activities of psychotropic drugs

    Type: Starting grantSource: European Research Council (ERC)

  • Modulating the gut microbiome with drugs (ID: GZ: MA 8164/11)

    Source: Emmy Noether Programme of German Research Foundation (DFG)

  • Real-time imaging of gut microbiome modulation

    Type: Collaborative research grantSource: CMFI Cluster of Excellence Tübingen

  • Screening stunting-associated microbes for their growth in the presence of polyphenols and different fibers/carbohydrates (ID: INV-004352)

    Source: Bill and Melinda Gates Foundation

  • Systematic Triangulation of Pathobiont-Host-Interactions (SOAR)

    Type: ERC Starting GrantSource: European Research Council

  • Understanding metabolism-dependent differences in bacterial drug susceptibility

    Type: Collaborative research grantSource: Cluster of Excellence “Controlling Microbes to Fight Infections” Drug-Microbiome-Host-Interactions - AG Maier

Microbiome-immune interactions - AG Mager

  • Bacteria alter the function of driver mutations in colorectal cancer

    Source: Fritz Thyssen Foundation

  • Identification of Bifidobacterium pseudolongum derived co-stimulatory molecule driving anti-tumor immunity

    Type: Explorative grantSource: CMFI Cluster of Excellence Tübingen

  • Identification of new checkpoint blockade inhibitors through an unbiased, novel screening platform

    Type: iFIT flex fundingSource: iFIT Cluster of Excellence Tübingen

  • Systematic Triangulation of Pathobiont-Host-Interactions

    Source: European Cesearch Council

  • The microbiome as a crucial modulator for cancer development and therapy efficacy

    Source: Max Eder Program by German Cancer Aid Microbiome-immune interactions - AG Mager

Data science methods for biomedical research - AG Nahnsen

  • Carl Zeiss Grant

    Source: Carl Zeiss Foundation

  • CMFI Plattform (Exzellenzcluster 2124)

    Source: German Research Foundation (DFG)

  • DZIF-Infection Digital TI BBD

    Source: Deutsches Zentrum für Infektionsforschung

  • DZIF-IT Plattform TI BBD

    Source: Helmholtz Zentrum für Infektionsforschung

  • EXIST - Biocompile

    Source: Startup Center of the University of Tübingen

  • GHGA

    Source: German Research Foundation (DFG)

  • Horizon Europe

    Source: THRIVE

  • iFIT (Cluster of Excellence 2180)

    Source: German Research Foundation (DFG)

  • IRTG Women’s health (B. Derntl)

    Source: German Research Foundation (DFG)

  • nf-co2footprint

  • NFDI4Immuno

    Source: National Research Data Infrastructure (NFDI)

  • Seqera Labs Cooperation

  • UNC Chapel Hill Cooperation Projects

    Partner: The University of North Carolina at Chapel Hill Data science methods for biomedical research

Tumor immune microenvironment - AG Ruf

  • Clinician-Scientist Program MINT-CS

    Source: Medical Faculty Tübingen via German Research Foundation (DFG)

  • Image-Guided and Functionally Instructed Tumor Therapies – iFIT (Cluster of Excellence 2180)

    Source: German Research Foundation (DFG)

  • Jung Karriereförderpreis

    Source: Jung-Stiftung für Wissenschaft und Forschung

  • Max-Eder Junior Research Group

    Source: Deutsche Krebshilfe

  • Response features, efficacy and safety of CD318-targeted CAR-T cell therapy against pancreatic cancer – ResCPa study

    Source: Federal Ministry of Education and Research (BMBF) Tumor immune microenvironment - AG Ruf

Dynamic interactions in metabolically relevant tissues - AG Sbierski-Kind

  • Clinician Scientist Programme

    Source: Deutsche Gesellschaft für Innere Medizin e.V. (DGIM)

  • DDG Sachmittelantrag 2025

    Type: SachmittelantragSource: Deutsche Diabetes Gesellschaft e.V.

  • DZD Young Investigator Funding

    Source: Deutsches Zentrum für Diabetisforschung (DZD)

  • Nachwuchsgruppenleiterstelle (Junior group leader position)

    Source: Medical faculty – University of Tübingen Dynamic interactions in metabolically relevant tissues - AG Sbierski-Kind

Metabolomics & Systems Medicine - AG Trautwein

  • ENDO-RELIEF Subproject 2: Correlative stratification of endometriosis lesions using biofluids and tissue metabolomics

    Type: BMBF Endometriosis Project

  • Metabolic phenotyping by timsTOF technology

    Type: Research CollaborationSource: BRUKER Switzerland AG, Industriestr. 26, CH-8117 Faellanden Metabolomics & Systems Medicine - AG Trautwein